Download Free Substitutes Or Complements Alcohol Cannabis And Tobacco Book in PDF and EPUB Free Download. You can read online Substitutes Or Complements Alcohol Cannabis And Tobacco and write the review.

This book is the first to present an extensive analysis of the international evidence for the similarities of the consumption patterns of such controversial commodities as alcohol, tobacco and marijuana, using recent data from a number of developed and less developed countries over a number of years. The book also presents analysis of the consumption patterns of food in general and soft drinks in particular. In addition the book provides a detailed analysis of the consumption restrictions and regulations in place in various countries in relation to issues associated with taxation, availability, and marketing of these products. The book's focus is on rigorous empirical analysis and presents the estimates of demand elasticities of these five commodities across different countries. Such estimates are key inputs for government economic models that are used for the purpose of social policy analysis. Furthermore, the book presents hypothesis testing results on various demand theory hypotheses such as demand homogeneity and Slutsky symmetry.
Conventional wisdom once held that the demand for addictive substances like cigarettes, alcohol, and drugs was unlike that for any other economic good and, therefore, unresponsive to traditional market forces. Recently, however, researchers from two disparate fields, economics and behavioral psychology, have found that increases in the overall price of an addictive substance can significantly reduce both the number of users and the amounts those users consume. Changes in the "full price" of addictive substances—including monetary value, time outlay, effort to obtain, and potential penalties for illegal use—yield marked variations in behavioral outcomes and demand. The Economic Analysis of Substance Use and Abuse brings these distinctive fields of study together and presents for the first time an integrated assessment of their data and results. Unique and innovative, this multidisciplinary volume will serve as an important resource in the current debates concerning alcohol and drug use and abuse and the impacts of legalizing illicit drugs.
Are the risks of smoking exaggerated? Has there been an open and rational discussion about the risks of smoking? This book attempts to answer these and many other questions about the subject, providing a detailed empirical presentation on smoking behavior as a risky consumer decision. Using new empirical data based on several national and regional surveys, Viscusi addresses a number of important issues, including: the sources of information that people have about the risks of smoking, the accuracy of their perceptions of the risks associated with smoking, and the consistency of smoking decisions with other risky behavior - scrutinizing issues such as whether smokers value risk differently than those who wear safety belts. Viscusi also looks at the differences in age groups and how they assess these risks based on public information. He provides new insight into the degree to which individuals understand smoking risks and take these risks into account in their behavior. With its detailed empirical data and its examination of individual decision-making processes, this work will interest researchers in public health, public policy, psychology, and economics, as well as anyone concerned with this important issue.
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
This book promotes the interaction between research and professional practices in the field of prevention and harm reduction. Through the scientific work and experience of human and social sciences researchers and medical social actors, research and action assist one another in illuminating the problems associated with the consumption of psychotropic drugs and in developing intervention strategies.Over the course of several chapters, contributed by attendees of the Psychotropics, Prevention and Harm Reduction Put to the Test By "Human and Social Sciences workshop, a range of varied themes are explored within the scope of drugs and their uses. Both the socio-historical context of drug uses and the construction of prevention and harm reduction public policies in light of scientific knowledge are covered, as well as the issue of release, mobilization and/or negotiation of prevention and harm reduction standards, both for professionals and drug users. - Presents acts that formalize the first day of study initiated by the network of young researchers at the Psychotropes and Societies Intervention - Offers a multidisciplinary view on the understanding of the use of psychotropic substances - Includes different analyses to stimulate reflection
Microeconomics: Case Studies and Applications contains case studies that explore core microeconomics concepts by focusing on current events in economics and providing a theory refresher for each section and questions. Designed to be a companion text to larger microeconomics texts, this resource offers a useful, time-saving alternative to sourcing online articles and journals. As a first-year text it teaches best-practice use of case studies and acts as a stepping stone for students who will source and use articles as they progress through their course. Each case study presents a different application of a core concept or theory. As well as the main text, which presents the application of the core concept, each case study contains a range of extra material. A ‘Theory refresher’ section provides a quick way for students to revise a key concept or theory that is important for understanding the application in that case study.
A fascinating analysis of a widely used, but little understood illicit drug.
Tobacco use by adolescents and young adults poses serious concerns. Nearly all adults who have ever smoked daily first tried a cigarette before 26 years of age. Current cigarette use among adults is highest among persons aged 21 to 25 years. The parts of the brain most responsible for cognitive and psychosocial maturity continue to develop and change through young adulthood, and adolescent brains are uniquely vulnerable to the effects of nicotine. At the request of the U.S. Food and Drug Administration, Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products considers the likely public health impact of raising the minimum age for purchasing tobacco products. The report reviews the existing literature on tobacco use patterns, developmental biology and psychology, health effects of tobacco use, and the current landscape regarding youth access laws, including minimum age laws and their enforcement. Based on this literature, the report makes conclusions about the likely effect of raising the minimum age to 19, 21, and 25 years on tobacco use initiation. The report also quantifies the accompanying public health outcomes based on findings from two tobacco use simulation models. According to the report, raising the minimum age of legal access to tobacco products, particularly to ages 21 and 25, will lead to substantial reductions in tobacco use, improve the health of Americans across the lifespan, and save lives. Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products will be a valuable reference for federal policy makers and state and local health departments and legislators.